Cerity Partners
RDY icon

Cerity Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Cerity Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Buy
184,772
+3,177
+2% +$42.9K ﹤0.01% 1423
2026
Q1 		$2.52M Buy
181,595
+892
+0.5% +$12.4K ﹤0.01% 1353
2025
Q4 		$2.54M Buy
180,703
+11,378
+7% +$160K ﹤0.01% 1267
2025
Q3 		$2.37M Sell
169,325
-4,450
-3% -$64K ﹤0.01% 1218
2025
Q2 		$2.61M Sell
173,775
-18,442
-10% -$263K ﹤0.01% 1089
2025
Q1 		$2.54M Buy
192,217
+88,628
+86% +$1.22M 0.01% 1006
2024
Q4 		$1.91M Buy
103,589
+9,664
+10% +$145K ﹤0.01% 1124
2024
Q3 		$1.49M Buy
93,925
+38,545
+70% +$620K ﹤0.01% 1220
2024
Q2 		$844K Sell
55,380
-32,110
-37% -$460K ﹤0.01% 1307
2024
Q1 		$1.28M Buy
87,490
+24,950
+40% +$364K ﹤0.01% 1161
2023
Q4 		$870K Buy
62,540
+7,520
+14% +$101K ﹤0.01% 1037
2023
Q3 		$736K Buy
55,020
+2,865
+5% +$38.8K ﹤0.01% 846
2023
Q2 		$658K Buy
52,155
+5,680
+12% +$66.3K ﹤0.01% 1074
2023
Q1 		$2.13M Buy
46,475
+5,505
+13% +$59.4K 0.01% 706
2022
Q4 		$424K Buy
40,970
+5,960
+17% +$64.3K ﹤0.01% 1006
2022
Q3 		$366K Buy
35,010
+2,985
+9% +$31.8K ﹤0.01% 822
2022
Q2 		$355K Buy
+32,025
New +$348K ﹤0.01% 851
2022
Q1 		– Sell
-24,810
Closed -$324K – 1075
2021
Q4 		$324K Buy
+24,810
New +$313K ﹤0.01% 744

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cerity Partners's RDY Position: Q2 2026 in Review

Cerity Partners increased its Dr. Reddy's Laboratories (RDY) stake by 1.7% in Q2 2026, buying an estimated $42.9K and bringing the position to 184,772 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Cerity Partners first reported a position in RDY in Q4 2021 and has held it in 18 quarters since. 226 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Cerity Partners held 184,772 shares of Dr. Reddy's Laboratories worth $2.68M as of Q2 2026.
  • Cerity Partners bought 3,177 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $42.9K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1423 holding.
  • Cerity Partners first reported a position in Dr. Reddy's Laboratories in Q4 2021 and has held it in 18 quarters since.
  • 226 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.